Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F73FH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,936
Award facts
- Contract value 100% obligated
- $12,936.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,936.02 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml syringes on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed price delivery order represents a non-competed, non-set-aside procurement executed under a competitive framework. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office, leveraging its extensive federal procurement experience and established distribution infrastructure to support military healthcare supply chains.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers. Dupixent is a biologic immunosuppressant used primarily for treating moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain asthma conditions, making this delivery order consistent with AmerisourceBergen's role as a critical vendor for specialized pharmaceutical support to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F73FH?
SPE2DR26F73FH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F73FH worth?
The government has obligated $12,936 on SPE2DR26F73FH.
Is contract SPE2DR26F73FH an order under another contract?
Yes. SPE2DR26F73FH is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73FH competed?
The extent of competition for SPE2DR26F73FH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award